OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
SIRT1 Promotes Cisplatin Resistance in Bladder Cancer via Beclin1 Deacetylation-Mediated Autophagy
Yan Sun, Xudong Liu, Hang Tong, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 125-125
Open Access | Times Cited: 9
Yan Sun, Xudong Liu, Hang Tong, et al.
Cancers (2023) Vol. 16, Iss. 1, pp. 125-125
Open Access | Times Cited: 9
Showing 9 citing articles:
Autophagy flux in bladder cancer: Cell death crosstalk, drug and nanotherapeutics
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
Kuan Liu, Huijing Chen, Yanhong Li, et al.
Cancer Letters (2024) Vol. 591, pp. 216867-216867
Closed Access | Times Cited: 5
The role of SIRT1 in autophagy and drug resistance: unveiling new targets and potential biomarkers in cancer therapy
Yujing Tang, Wantao Ju, Y. Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Yujing Tang, Wantao Ju, Y. Liu, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 3
Benserazide, a cystathionine beta-synthase (CBS) inhibitor, potentially enhances the anticancer effects of paclitaxel via inhibiting the S-sulfhydration of SIRT1 and the HIF1-α/VEGF pathway
Wei Zhao, Shasha Feng, Jian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Wei Zhao, Shasha Feng, Jian Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
The clinical significance and anti-tumor role of PRKG1 in bladder cancer
Jin Lu, Ting Chen, Huan Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Jin Lu, Ting Chen, Huan Sun, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Targeting autophagy in urological system cancers: From underlying mechanisms to therapeutic implications
Ziyue Yuan, Jiani He, Zhijia Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189196-189196
Closed Access | Times Cited: 1
Ziyue Yuan, Jiani He, Zhijia Li, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 6, pp. 189196-189196
Closed Access | Times Cited: 1
Empagliflozin enhances cisplatin activity in chemo-resistant EJ138 bladder cancer cells: The importance of anti-diabetic medications in cancer treatment
Saeedeh Shariati, Shokooh Mohtadi, Shahrzad Molavinia, et al.
Research Square (Research Square) (2024)
Closed Access
Saeedeh Shariati, Shokooh Mohtadi, Shahrzad Molavinia, et al.
Research Square (Research Square) (2024)
Closed Access
The role of autophagy dysregulation in low and high-grade nonmuscle invasive bladder cancer: A survival analysis and clinicopathological association
Anil Kumar, Mukul Kumar Singh, Vishwajeet Singh, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Closed Access
Anil Kumar, Mukul Kumar Singh, Vishwajeet Singh, et al.
Urologic Oncology Seminars and Original Investigations (2024)
Closed Access
Lei Li, Ning Yang, Jianhe Sun, et al.
The Kaohsiung Journal of Medical Sciences (2024)
Open Access
Evidenz für Ausmaß und onkologischen Nutzen der Lymphadenektomie beim Magenkarzinom
Matthias Kelm, Sven Flemming, Christoph-Thomas Germer, et al.
Deleted Journal (2024)
Closed Access
Matthias Kelm, Sven Flemming, Christoph-Thomas Germer, et al.
Deleted Journal (2024)
Closed Access
